IMRN

Immuron Ltd

1.800

+0.690+62.16%

After Hours: 1.680 -0.120 -6.67%19:59 09/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.810/1.110

TODAY RANGE1.540-1.990

VOL123.14M

MARKET CAP14.53M

52 WEEK RANGE0.6765-2.390

AVG VOL (3M)1.99M

% TURNOVER1,490.18%

TURNOVER--

P/E (TTM)-3.6065

% RANGE40.54%

EPS(TTM)-0.4991

P/E(FORWARD)-165.1376

P/B1.685

BVPS1.069

DIVIDEND--

P/S2.199

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP14.53M

SHARES OUTSTANDING8.07M

NEXT EARNINGS--

FREE FLOAT8.07M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·22h ago
Immuron To Launch PROIBS In U.S. After Australia Debut; Pre-market Shares Up
TipRanks·23h ago
Immuron to launch Proibs in the U.S.
NASDAQ·08/28 17:06
Immuron FY26 Revenue Rises 6% As Net Loss Narrows And Cash Surges
Seeking Alpha·08/28 10:12
Immuron reports FY results
TipRanks·08/13 10:29
Immuron CEO to Present Company’s Gut Health Pipeline at Emerging Growth Conference
TipRanks·07/21 10:33
Immuron CEO to Present TechKnow Invest Roadshow in Melbourne
TipRanks·07/20 12:27
Immuron Showcases Oral Antibody Platform in July 20 Investor Presentation
TipRanks·06/23 10:30
Immuron Completes Buy-Back of Unmarketable Parcels to Streamline Share Register
TipRanks·05/08 10:34
Immuron Showcases Oral Antibody Portfolio at Emerging Growth Conference
Seeking Alpha·04/17 11:34
Immuron Q3 sales rise 16% to A$1.5M
Seeking Alpha·02/25 11:14
Immuron reports 1H results
TipRanks·01/20 12:27
Immuron Reports Continued Travelan Sales Growth and ProIBS Launch in H1 FY26
TipRanks·12/12/2025 13:28
Immuron Limited Announces Quotation of New Securities on ASX
TipRanks·12/10/2025 17:59
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
TipRanks·12/10/2025 13:49
Why Is Immuron Stock (IMRN) Down Today?

Same Industry

Name/Symbol

Change%

Price

IMRN

MCK

BIIB

AMGN

SHPG

CELG-RT

LLY

CELG

TXMD

JNJ

ABBV

ZTS

GILD

NVO

BMY

ALXN

Pfizer

PFE

-1.25%

28.45

SNY

GCVRZ

NVS

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.